Cresco Labs Inc.
CRLBF
$0.80
-$0.02-2.28%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.55% | -6.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.55% | -6.33% | |||
| Cost of Revenue | 13.86% | -3.01% | |||
| Gross Profit | 15.24% | -9.45% | |||
| SG&A Expenses | 12.25% | -1.78% | |||
| Depreciation & Amortization | 41.45% | -0.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.15% | -2.42% | |||
| Operating Income | 19.58% | -37.67% | |||
| Income Before Tax | -28.70% | 96.79% | |||
| Income Tax Expenses | -233.38% | 689.12% | |||
| Earnings from Continuing Operations | 190.34% | 80.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -63.83% | 189.64% | |||
| Net Income | 228.49% | 85.08% | |||
| EBIT | 19.58% | -37.67% | |||
| EBITDA | 11.24% | -18.46% | |||
| EPS Basic | 226.18% | 85.25% | |||
| Normalized Basic EPS | -85.25% | -64.12% | |||
| EPS Diluted | 211.42% | 85.25% | |||
| Normalized Diluted EPS | -88.52% | -64.12% | |||
| Average Basic Shares Outstanding | 1.81% | 1.20% | |||
| Average Diluted Shares Outstanding | 29.68% | 1.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||